Monoclonal antibodies, or mAbs, are important tools in medicine. These laboratory-made proteins are widely used in treatments ...

New monoclonal antibodies directed against new targets are under development, and hopefully several will emerge as alternative agents in the armamentarium against RA. Monoclonal antibodies and ...

Antibodies that bind to a previously untargeted portion of the malaria parasite could lead to new monoclonal antibody ... only after a specific step in the development of the sporozoite, but ...

has become a global player in human monoclonal antibody (mAb) discovery and development, and it is now a driver of the general trend in the immunotherapy space toward the use of fully human mAbs ...

Biotechnology company YUMAB, a global provider of fully human monoclonal antibody (mAb) discovery and development, has recently relocated its headquarters and research and development labs to ...